• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 19-Apr-2018
SENSEX
34,427.29
95.61 (0.28%)
NIFTY
10,565.30
39.10 (0.37%)
EQUITY
    No Companies Visited

Back to news list
  • Dr Reddy's Lab drops on buzz surrounding Duvvada facility

    Dr Reddy's Laboratories fell 2.73% to Rs 2,342 at 12:41 IST on BSE on media reports that an establishment inspection report has been issued to the company's Duvvada facility with some issues raised in it.

    Meanwhile, the S&P BSE Sensex was up 39.46 points or 0.12% at 33,851.72.

    On the BSE, 52,000 shares were traded on the counter so far as against average daily volumes of 51,406 shares in the past one quarter. The stock had hit a high of Rs 2,415 and a low of Rs 2,299 so far during the day. The stock had hit a 52-week high of Rs 3,203.95 on 6 January 2017 and a 52-week low of Rs 1,901.65 on 11 August 2017.

    The stock had outperformed the market over the past one month till 2 January 2018, gaining 7.95% compared with the Sensex's 2.98% rise. The stock had, however, underperformed the market over the past one quarter, advancing 3.36% as against the Sensex's 8.08% rise. The scrip had also underperformed the market over the past one year, sliding 22.02% as against the Sensex's 27.14% rise.

    The large-cap company has equity capital of Rs 82.94 crore. Face value per share is Rs 5.

    According to a media report, an establishment inspection report (EIR) has been issued to Dr Reddy's Laboratories' Duvvada facility by the United States Food and Drug Administration. The report further stated that Duvvada facility status continues to be classified as official action initiated (OAI). In pharmaceuticals parlance, OAI means regulatory/admin sanctions by the drug regulator are initiated, as per reports.

    On a consolidated basis, Dr Reddy's Laboratories' net profit fell 1.1% to Rs 305.40 crore on 1.1% decline in net sales to Rs 3546 crore in Q2 September 2017 over Q2 September 2016.

    Dr Reddy's Laboratories is an integrated global pharmaceutical company.

    Back to news list
Previous Stories :
More
Hot Pursuit News

Quick Links

Since 1986, Capital Market Publishers India Pvt Ltd is undertaking equity research, publishing an investment fortnightly magazine, data-vending and software production. Analysts track industry, companies and the economy. Branches in the metros and major cities ensure comprehensive coverage.

The major strength is equity research. Stock-picking for investor’s portfolio is preceded by rigorous research. The advisory services are transmitted through Capital Market magazine, newsletters, Telefolio. Almost 85% of the scrip’s recommended by us show appreciation. On an average we outperform the Bombay Stock Exchange Sensitive Index twice over, and sometime three times. Our independent status insulates us from influence from brokers and other market participants, ensuring that the selection of stocks and research are unbiased.

We are also pioneers in corporate databases - Capitaline, Mutual Fund database - Navindia

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine Print Edition queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 19-Apr-2018
  •  ( 15:47) Sensex, Nifty register modest gains on positive global cues  
  •  ( 14:47) IndusInd Bank Q4 PAT up 26.81% at Rs 953.09 cr  
  •  ( 14:24) BP and RIL sanction 2nd phase of integrated KGD6 development  
  •  ( 12:18) Rupee hits 7-month low against the US dollar as oil rises  
  •  ( 11:30) PSU OMCs slump as crude oil boils  
  •  ( 10:37) Metal and mining stocks shine  
  •  ( 09:45) Bharat Dynamics signs licensing agreement with DRDO  
  •  ( 08:06) ACC consol. PAT up 18.48% at Rs 250 crore  
  •  ( 08:03) Asian stocks rise  
  •  ( 07:49) Container Corp to consider stock split on April 30  
Show News
19 April 2018 00:00
386.45
(0.49 %)
1166.80
(-0.38 %)
513.50
(-1.00 %)
2855.10
(-0.26 %)
394.95
(2.64 %)
282.85
(-0.77 %)
2130.40
(1.60 %)
1864.45
(-0.65 %)
1941.95
(0.25 %)
3729.25
(-0.34 %)
1454.25
(0.20 %)
289.15
(-0.36 %)
1834.10
(-0.57 %)
1132.70
(0.64 %)
277.00
(0.62 %)
1155.20
(-0.24 %)
1384.30
(1.74 %)
803.10
(0.48 %)
9076.55
(-0.51 %)
177.45
(-0.48 %)
183.15
(0.74 %)
208.20
(1.61 %)
941.25
(0.45 %)
246.25
(0.00 %)
508.80
(-0.61 %)
334.85
(-0.19 %)
191.45
(0.26 %)
620.55
(3.17 %)
3190.65
(0.99 %)
291.60
(-0.38 %)
318.00
(2.83 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.